Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ASP388B |
| Synonyms | |
| Therapy Description |
Limited information is currently available on ASP388B (Sep 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ASP388B | ASP-388B|ASP 388B | Limited information is currently available on ASP388B (Sep 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07730021 | Phase Ib/II | ASP388B + Carboplatin + Fluorouracil + Pembrolizumab ASP388B + Fluorouracil + Oxaliplatin + Pembrolizumab ASP388B | A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors | Recruiting | USA | 1 |